-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 FnR3J1ROnn639V+ynHIrEGvwUj9DBF8GggiUpi9qK/cicwZHcJGs0QVR+2trEC+K
 Ox1NAvVvYONl9+WOhAOwMA==

<SEC-DOCUMENT>0000950147-96-000160.txt : 19960509
<SEC-HEADER>0000950147-96-000160.hdr.sgml : 19960509
ACCESSION NUMBER:		0000950147-96-000160
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		19960508
SROS:			NASD

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORTHOLOGIC CORP
		CENTRAL INDEX KEY:			0000887151
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				860585310
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21214
		FILM NUMBER:		96557931

	BUSINESS ADDRESS:	
		STREET 1:		2850 S 36TH ST #16
		CITY:			PHOENIX
		STATE:			AZ
		ZIP:			85034
		BUSINESS PHONE:		6024375520

	MAIL ADDRESS:	
		STREET 1:		2850 S 36TH ST
		STREET 2:		SUITE 16
		CITY:			PHOENIX
		STATE:			AZ
		ZIP:			85034
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<DESCRIPTION>FORM DEFA14A
<TEXT>

                            SCHEDULE 14A INFORMATION
                Proxy Statement Pursuant to Section 14(a) of the
                         Securities Exchange Act of 1934

Filed by the Registrant...............................................[X]
Filed by a Party other than the Registrant............................[ ]

Check the appropriate box:

[ ]  Preliminary Proxy Statement
[ ]  Confidential,  for  Use  of the  Commission  Only  (as  permitted  by  Rule
     14a-6(e)(2))
[ ]  Definitive Proxy Statement 
[X]  Definitive  Additional Materials
[ ]  Soliciting Material Pursuant to ss. 240.14a-11(c) or ss. 240.14a-12

                                OrthoLogic Corp.
     ----------------------------------------------------------------------
                (Name of Registrant As Specified In Its Charter)


     ----------------------------------------------------------------------
     (Name of Person(s) Filing Proxy Statement if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

[ ] $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i)(1), 14a-6(i)(2) or Item
    22(a)(2) of Schedule 14A.
[ ] $500  per  each  party  to  the  controversy  pursuant  to Exchange Act Rule
    14a-6(i)(3).
[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

         1)      Title of each class of securities to which transaction applies:

         2)      Aggregate number of securities to which transaction applies:

         3)      Per  unit  price  or other  underlying  value  of  transaction
                 computed  pursuant  to  Exchange  Act Rule 0-11 (Set forth the
                 amount on which the filing fee is calculated  and state how it
                 was determined):

         4)      Proposed maximum aggregate value of transaction:

         5)      Total fee paid:

[X]      Fee paid previously with preliminary materials.
[ ]      Check  box  if any part of the fee is offset as  provided  by  Exchange
         Act Rule  0-11(a)(2)  and identify the filing for which the  offsetting
         fee was paid  previously.  Identify the previous filing by registration
         statement number, or the Form or Schedule and the date of its filing.
         1)       Amount Previously Paid:
                                         ---------------------------------------
         2)       Form, Schedule or Registration Statement No.:
                                                               -----------------
         3)       Filing Party:
                               -------------------------------------------------
         4)       Date Filed:
                             ---------------------------------------------------
<PAGE>
May 7, 1996



Ms. Jill Lyons
Director, Proxy Advisory Services
Institutional Shareholder Services
7200 Wisconsin Avenue, Suite 1001
Bethesda, MD  20814

RE:  OrthoLogic Corp./1987 Stock Option Plan

Dear Ms. Lyons:

This letter  confirms that  OrthoLogic's  Board of Directors  intends to adopt a
resolution prohibiting the repricing of outstanding stock options.  Furthermore,
the  resolution  disallows the surrender of  outstanding  options in conjunction
with a grant of new options in substitution  therefor at an exercise price lower
than the price of the options surrendered.

Should you have any questions concerning this matter,  please do not hesitate to
contact me at 602.437.5520.

Sincerely,



Allen R. Dunaway
Vice President, Chief Financial Officer
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
